ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,801 | 63.93399 | 1 |
male
| 0 | 18 | 926 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 0 | 39,951 | 23,115.0156 | null | 29.666656 |
white
| 38 | 62 | 0.404968 | 0.28595 | 15 | 1 | 0 |
no
| 0.25 | 0.5 |
no dnr
| 18 | 49 | 10.798828 | 122 | 38 | 38.79688 | 174 | 2.599609 | 0.899902 | 5.199219 | 139 | 7.349609 | null | null | null | 0 | null | null | 0.4948 |
1,802 | 73.336 | 1 |
male
| 1 | 6 | 6 |
Lung Cancer
|
Cancer
| 2 | 8 | null | 0 | 6,528 | 4,465.707 | null | 18 |
white
| 18.199219 | 19 | 0.661987 | 0.358948 | 1 | 0 | 0 |
metastatic
| 0.1 | 0.001 |
dnr after sadm
| 1 | 79 | 4.699219 | 100 | 24 | 36.79688 | 433.3125 | 3.399902 | 0.599976 | 0.799927 | 134 | 7.359375 | null | null | null | 0 | 0 |
<2 mo. follow-up
| 0 |
1,803 | 57.21799 | 0 |
male
| 0 | 5 | 1,875 |
Lung Cancer
|
Cancer
| 1 | 7 | null | 0 | 6,209 | 3,865.9766 | null | 22 |
white
| 9.699219 | 15 | 0.837891 | 0.645996 | 1 | 0 | 0 |
metastatic
| 1 | 0.5 |
no dnr
| 5 | 106 | 6.599609 | 88 | 20 | 36.79688 | null | 3.899902 | 0.899902 | 1.199951 | 141 | null | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
1,804 | 64.58899 | 1 |
male
| 0 | 20 | 61 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 20,287 | 12,675.5625 | null | 17.333328 |
white
| 17.796875 | 34 | 0.883911 | 0.805908 | 1 | 1 | 0 |
no
| 0.8 | 0.6 |
dnr after sadm
| 8 | 75 | 6.599609 | 80 | 24 | 36.59375 | 490 | 3.599609 | 1.299805 | 1.5 | 130 | 7.459961 | null | null | null | null | null | null | 2.582031 |
1,805 | 73.73297 | 0 |
male
| 0 | 18 | 1,873 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 0 | 35,954 | 25,675.9688 | null | 27.333328 |
white
| 23.199219 | 55 | 0.787964 | 0.718994 | 1 | 1 | 0 |
no
| 0.75 | 0.6 |
no dnr
| 18 | 105 | 9.898438 | 112 | 28 | 39.09375 | 332 | 2.399902 | null | 2 | 143 | 7.5 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
1,806 | 61.01599 | 1 |
male
| 0 | 22 | 130 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 14 |
$11-$25k
| 0 | 43,814 | 19,164 | null | 36.333313 |
white
| 32.59375 | 36 | 0.317993 | 0.204987 | 7 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 16 | 48 | 4 | 118 | 34 | 38 | 372 | null | 1.5 | 1.299805 | 148 | 7.40918 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,807 | 43.26898 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 11,032 | 4,530.9414 | null | 47 |
white
| 52.398438 | 89 | 0.243988 | 0.140991 | 1 | 0 | 0 |
no
| 0.01 | 0.000001 |
no dnr
| 4 | 43 | 28 | 140 | 26 | 39 | 72 | 2.299805 | 4 | 3.799805 | 137 | 7.279297 | null | null | null | null | null |
<2 mo. follow-up
| 2.13916 |
1,808 | 61.63397 | 0 |
male
| 0 | 11 | 1,867 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 8 |
under $11k
| 0 | 13,547 | 7,884.6055 | null | 10.5 |
white
| 24 | 39 | 0.825928 | 0.716919 | 1 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 11 | 85 | 7.199219 | 160 | 24 | 36.09375 | null | null | 2.399902 | 1.599854 | 141 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,809 | 83.30194 | 1 |
male
| 0 | 5 | 130 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 12 |
under $11k
| 0 | 3,822 | 2,581.4356 | null | 13 |
white
| 24.398438 | 36 | 0.727905 | 0.573975 | 1 | 0 | 0 |
no
| 0.9 | 0.5 |
dnr after sadm
| 1 | 71 | 10.398438 | 54 | 24 | 35.59375 | 290 | null | null | 2.399902 | 139 | 7.449219 | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
1,810 | 83.01996 | 1 |
female
| 0 | 20 | 1,577 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 | null | 0 | 21,266 | 11,367.5859 | null | 19 |
white
| 28.699219 | 50 | 0.619995 | 0.514893 | 2 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 20 | 53 | 17.5 | 68 | 32 | 36.5 | 156 | 2.599609 | 1.199951 | 0.599976 | 140 | 7.369141 | null | null | null | 3 | 0 |
no(M2 and SIP pres)
| 0 |
1,811 | 49.28699 | 0 |
female
| 0 | 31 | 1,866 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 14 | null | 0 | 106,935 | 81,057.125 | null | 25.75 |
black
| 35.296875 | 57 | 0.562988 | 0.450989 | 36 | 0 | 0 |
no
| 0.85 | 0.9 |
no dnr
| 31 | 75 | 17.398438 | 112 | 0 | 38.5 | 146 | null | null | 3.199707 | 149 | 7.389648 | null | null | null | null | 2 |
SIP>=30
| 2 |
1,812 | 65.46198 | 1 |
female
| 1 | 18 | 18 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 0 | 68,682 | 57,570.2188 | null | 42.666657 |
white
| 26.398438 | 47 | 0.740967 | 0.660889 | 3 | 1 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 9 | 63 | 16.5 | 75 | 20 | 38.59375 | 140 | null | 1.299805 | 5.699219 | 137 | 7.349609 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
1,813 | 75.63898 | 1 |
male
| 0 | 7 | 322 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 7 |
$25-$50k
| 0 | 5,284 | 3,609.7305 | null | 5 |
white
| 19.097656 | 26 | 0.839966 | 0.737915 | 1 | 0 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 7 | 105 | 5.399414 | 68 | 24 | 37 | 235 | null | null | 2.5 | 142 | 7.449219 | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
1,814 | 54.43698 | 0 |
male
| 0 | 8 | 1,864 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
$25-$50k
| 0 | 12,503 | 7,265.9961 | null | 25 |
white
| 19.296875 | 25 | 0.894897 | 0.823975 | 1 | 1 | 0 |
no
| 0.5 | 0.125 |
no dnr
| 8 | 75 | 10 | 106 | 24 | 36.39844 | 300 | null | null | 1.399902 | 138 | 7.469727 | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
1,815 | 49.61499 | 1 |
female
| 1 | 11 | 11 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 0 | 42,791 | 33,042.8438 | null | 46.5 |
white
| 32.695313 | 58 | 0.352966 | 0.235992 | 5 | 0 | 0 |
metastatic
| 0.5 | 0.1 |
dnr after sadm
| 8 | 55 | 23.199219 | 150 | 10 | 39.19531 | 140 | 1.899902 | null | 0.5 | 146 | 7.359375 | null | null | null | null | null |
<2 mo. follow-up
| 2.501953 |
1,816 | 40.68698 | 1 |
female
| 1 | 18 | 18 |
Lung Cancer
|
Cancer
| 1 | 14 |
>$50k
| 0 | 26,951 | 17,289.8281 | null | 15.666664 |
asian
| 21.597656 | 22 | 0.671997 | 0.373962 | 1 | 0 | 0 |
metastatic
| 0.1 | 0.001 |
dnr after sadm
| 5 | 83 | 5.799805 | 80 | 28 | 36.29688 | null | 2.799805 | 1.899902 | 1.699951 | 136 | null | null | null | null | 1 | 0 |
<2 mo. follow-up
| 0 |
1,817 | 41.448 | 0 |
male
| 0 | 13 | 1,861 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 16 |
>$50k
| 0 | 15,982 | 8,234.9922 | null | 13.5 |
white
| 24.296875 | 42 | 0.826904 | 0.716919 | 1 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 13 | 57 | 9.5 | 60 | 40 | 36.19531 | null | 2.099609 | 2.699707 | 0.599976 | 137 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,818 | 75.34296 | 0 |
male
| 0 | 7 | 1,859 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 5,532 | 3,669.9375 | null | 9 |
black
| 17.097656 | 27 | 0.862915 | 0.772949 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 100 | 6.699219 | 60 | 20 | 37 | 242.84375 | null | 0.799927 | 1.699951 | 139 | 7.429688 | null | null | null | 0 | 1 |
no(M2 and SIP pres)
| 1 |
1,819 | 69.35797 | 1 |
female
| 0 | 6 | 1,471 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 14 | null | 0 | 4,764 | 3,248.6406 | null | 10 |
white
| 14.199219 | 25 | 0.899902 | 0.831909 | 1 | 0 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 6 | 98 | 8.298828 | 80 | 24 | 37 | 259.25 | null | null | 1.399902 | 140 | 7.469727 | null | null | null | 5 | 4 |
SIP>=30
| 4 |
1,820 | 54.43399 | 1 |
male
| 0 | 5 | 11 |
Lung Cancer
|
Cancer
| 1 | null | null | 0 | 4,818 | 3,069.916 | null | 12 |
black
| 22.296875 | 16 | 0.618896 | 0.304993 | 1 | 0 | 0 |
metastatic
| null | null |
dnr before sadm
| -1 | 100 | 13.398438 | 120 | 20 | 37.79688 | null | 3.199707 | 0.599976 | 0.899902 | 142 | null | null | null | null | null | null |
<2 mo. follow-up
| 2.205566 |
1,821 | 75.07996 | 1 |
female
| 0 | 21 | 52 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 5 |
under $11k
| 0 | 39,957 | 32,404.2969 | null | 40.333313 |
white
| 20.699219 | 24 | 0.804932 | 0.68396 | 1 | 0 | 0 |
no
| 0.19 | 0.19 |
dnr after sadm
| 6 | 117 | 11.5 | 64 | 6 | 38.39844 | 206.65625 | 3 | null | 1.599854 | 142 | 7.349609 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
1,822 | 54.66397 | 1 |
female
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 96,588 | 50,266.9688 | null | 43 |
white
| 54.398438 | 87 | 0.051994 | 0.016998 | 23 | 0 | 0 |
no
| 0.5 | 0.3 |
no dnr
| 8 | 57 | 3.099609 | 140 | 26 | 35.79688 | 160 | 3 | 33 | 3.699707 | 132 | 7.379883 | null | null | null | null | null |
<2 mo. follow-up
| 1.996094 |
1,823 | 72.40497 | 0 |
male
| 0 | 10 | 1,855 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 10 | null | 0 | 48,378 | 31,511.7344 | null | 28.5 |
white
| 21.199219 | 33 | 0.777954 | 0.705933 | 7 | 1 | 0 |
no
| 0.93 | 0.9 |
no dnr
| 10 | 69 | 12.699219 | 110 | 28 | 39 | 220 | null | null | 0.899902 | 143 | 7.469727 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,824 | 75.12695 | 1 |
female
| 0 | 16 | 1,013 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 9 | null | 0 | 53,401 | 33,741.6562 | null | 14.333328 |
white
| 20.5 | 33 | 0.806885 | 0.687988 | 1 | 0 | 0 |
no
| 0.8 | 0.4 |
no dnr
| 16 | 87 | 6.699219 | 70 | 26 | 35.19531 | 217.375 | null | 0.399963 | 1.5 | 144 | 7.329102 | null | null | null | 5 | 7 |
SIP>=30
| 7 |
1,825 | 65.05096 | 1 |
male
| 0 | 8 | 177 |
Lung Cancer
|
Cancer
| 2 | 16 |
$25-$50k
| 0 | 6,174 | 4,199.1641 | null | 5 |
white
| 14.798828 | 9 | 0.748901 | 0.487976 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.3 |
no dnr
| 8 | 85 | 4.799805 | 72 | 18 | 36.29688 | null | 3.599609 | 0.799927 | 0.799927 | 147 | null | null | null | null | 4 | 0 |
SIP>=30
| 0 |
1,826 | 62.35498 | 1 |
male
| 1 | 28 | 28 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 20 | null | 9 | 45,424 | 36,292.4062 | null | 29.75 |
white
| 35.898438 | 55 | 0.543945 | 0.429993 | 1 | 1 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 26 | 55 | 2.199707 | 105 | 28 | 38.69531 | 179.5625 | 3.299805 | 0.699951 | 2.299805 | 132 | 7.469727 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
1,827 | 51.767 | 1 |
female
| 1 | 9 | 9 |
Colon Cancer
|
Cancer
| 1 | 12 |
under $11k
| 0 | 6,608 | 4,792.4727 | null | 11.5 |
white
| 40.59375 | 38 | 0.305969 | 0.052994 | 1 | 0 | 0 |
metastatic
| 0.1 | 0.001 |
dnr after sadm
| 1 | 70 | 15.199219 | 128 | 22 | 36.59375 | null | 2.5 | 12.298828 | 0.699951 | 137 | null | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
1,828 | 72.64099 | 1 |
male
| 0 | 22 | 1,489 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 |
>$50k
| 0 | 30,733 | 16,213.8359 | null | 16 |
white
| 26.898438 | 42 | 0.688965 | 0.596924 | 4 | 1 | 0 |
no
| 0.95 | 0.85 |
no dnr
| 22 | 74 | 12.798828 | 76 | 24 | 36.09375 | 217.5 | 2 | 1.699951 | 3.899902 | 131 | 7.339844 | null | null | null | 0 | 1 | null | 1 |
1,829 | 87.70996 | 0 |
female
| 0 | 27 | 1,848 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
under $11k
| 100 | 46,354 | 16,436.5938 | null | 31.75 |
white
| 33.296875 | 47 | 0.051994 | 0.015999 | 1 | 0 | 1 |
no
| 0.5 | 0.25 |
no dnr
| 27 | 61 | 17.597656 | 107 | 28 | 36.19531 | 124.48438 | 3.399902 | 0.799927 | 2.5 | 136 | 7.299805 | null | null | null | null | 3 |
adl>=4 (>=5 if sur)
| 3 |
1,830 | 80.159 | 1 |
male
| 0 | 82 | 1,199 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 |
$25-$50k
| 0 | 131,511 | 100,763.688 | null | 29 |
white
| 26.796875 | 46 | 0.608887 | 0.50293 | 14 | 1 | 0 |
no
| 0.95 | 0.9 |
dnr after sadm
| 30 | 80 | 18 | 80 | 32 | 38.09375 | 98 | null | null | 1.899902 | 141 | 7.399414 | null | null | null | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
1,831 | 57.51999 | 1 |
female
| 0 | 6 | 106 |
Lung Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 6,630 | 4,241.5977 | null | 15 |
white
| 11.798828 | 12 | 0.810913 | 0.593994 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 6 | 83 | 6.899414 | 104 | 24 | 36.69531 | null | 3.899902 | 0.5 | 1.099854 | 142 | null | null | null | null | 0 | 3 |
no(M2 and SIP pres)
| 3 |
1,832 | 74.51599 | 1 |
male
| 1 | 4 | 4 |
Lung Cancer
|
Cancer
| 1 | 14 |
under $11k
| 9 | 3,122 | 2,082.5606 | null | 14 |
white
| 19.296875 | 37 | 0.594971 | 0.27594 | 1 | 0 | 0 |
metastatic
| 0.5 | 0 |
dnr after sadm
| 1 | 100 | 7.899414 | 60 | 5 | 36.09375 | null | 3.699707 | 0.699951 | 1.299805 | 147 | null | null | null | null | null | 3 |
<2 mo. follow-up
| 3 |
1,833 | 67.034 | 1 |
male
| 0 | 13 | 245 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 25,793 | 11,789.1562 | null | 17 |
white
| 19.5 | 29 | 0.860962 | 0.769897 | 1 | 0 | 0 |
no
| 0.95 | 0.8 |
no dnr
| 13 | 70 | 13.298828 | 54 | 26 | 36.69531 | 240 | 3.399902 | 0.599976 | 1.199951 | 137 | 7.399414 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,834 | 65.53894 | 0 |
male
| 0 | 10 | 1,846 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 19 |
>$50k
| 0 | 10,474 | 6,287.6641 | null | 14 |
white
| 16 | 21 | 0.896973 | 0.826904 | 1 | 0 | 0 |
no
| 0.75 | 0.5 |
no dnr
| 10 | 85 | 5.599609 | 92 | 22 | 37.19531 | 385.6875 | null | null | 1.5 | 136 | 7.5 | null | null | null | 0 | 0 | null | 0 |
1,835 | 76.44397 | 1 |
female
| 0 | 7 | 181 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
under $11k
| 0 | 5,718 | 3,549.4473 | null | 15 |
white
| 27 | 37 | 0.713989 | 0.554932 | 1 | 1 | 0 |
no
| 0.91 | 0.91 |
no dnr
| 7 | 117 | 8.099609 | 70 | 20 | 36.09375 | 211.09375 | 2.799805 | null | 3.5 | 141 | 7.419922 | null | null | null | 0 | 1 |
no(M2 and SIP pres)
| 1 |
1,836 | 75.27698 | 1 |
male
| 0 | 7 | 30 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | null | null | 0 | 6,045 | 3,920.6856 | null | 17 |
white
| 19.699219 | 36 | 0.833984 | 0.727905 | 1 | 0 | 0 |
no
| 0.95 | 0.75 |
no dnr
| 7 | 65 | 11.398438 | 64 | 22 | 37.59375 | 197.5 | null | null | 1.699951 | 145 | 7.479492 | null | null | null | 3 | 0 |
<2 mo. follow-up
| 0 |
1,837 | 84.41595 | 0 |
male
| 0 | 8 | 1,843 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 4 | null | 0 | 11,238 | 8,764.9141 | null | 21 |
white
| 22.597656 | 41 | 0.68396 | 0.514893 | 2 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 8 | 57 | 8.199219 | 61 | 34 | 37.59375 | 197.5 | 3 | 0.899902 | 1.699951 | 135 | 7.40918 | null | null | null | 0 | 3 |
no(M2 and SIP pres)
| 3 |
1,838 | 82.09399 | 1 |
male
| 1 | 4 | 4 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 13,125 | 9,268.6562 | null | 32 |
white
| 31.597656 | 59 | 0.360962 | 0.168976 | 4 | 0 | 1 |
yes
| 0.1 | 0.001 |
dnr after sadm
| 2 | 68 | 13.398438 | 85 | 40 | 37.19531 | 185.6875 | 2.399902 | 0.699951 | 2 | 132 | 7.529297 | null | null | null | null | null |
<2 mo. follow-up
| 5.226563 |
1,839 | 78.25598 | 1 |
female
| 1 | 4 | 4 |
Coma
|
Coma
| 0 | null | null | 0 | 7,774 | 2,277.2676 | null | 12 |
white
| 25.296875 | 43 | 0.498962 | 0.427979 | 3 | 0 | 0 |
no
| 0 | 0 |
no dnr
| 4 | 67 | null | 128 | 4 | 41.09375 | null | null | null | null | 140 | null | null | null | null | null | null |
<2 mo. follow-up
| 1.734863 |
1,840 | 81.56299 | 0 |
female
| 0 | 14 | 1,842 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 15,296 | 8,135.9922 | null | 13.666664 |
white
| 21.898438 | 29 | 0.763916 | 0.688965 | 2 | 1 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 14 | 54 | 7.5 | 59 | 24 | 38.69531 | 330 | null | null | 0.799927 | 129 | 7.439453 | null | null | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
1,841 | 61.306 | 1 |
female
| 0 | 32 | 830 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 74,086 | 60,316.625 | null | 29.5 |
white
| 41.5 | 56 | 0.348999 | 0.232971 | 7 | 0 | 0 |
no
| 0.02 | 0.000008 |
dnr after sadm
| 1 | 41 | 34.398438 | 210 | 24 | 38.39844 | 96.25 | 3 | null | 1.399902 | 144 | 7.30957 | null | null | null | null | null | null | 2.189941 |
1,842 | 70.68896 | 1 |
female
| 1 | 17 | 17 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 49,259 | 22,383.4375 | null | 42 |
white
| 40.898438 | 52 | 0.389954 | 0.270996 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
dnr after sadm
| 14 | 46 | 14 | 126 | 10 | 36.59375 | 153.03125 | 2.799805 | 0.599976 | 4.5 | 140 | 7.229492 | null | null | null | null | 2 |
<2 mo. follow-up
| 2 |
1,843 | 89.31396 | 1 |
male
| 1 | 28 | 28 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null | null | 9 | 26,630 | 16,067.7109 | null | 11.5 |
white
| 22.5 | 47 | 0.602905 | 0.412964 | 2 | 0 | 1 |
no
| 0.6 | 0.3 |
dnr before sadm
| -1 | 123 | 10.898438 | 62 | 28 | 38.09375 | 286.625 | 3.099609 | null | 1.799805 | 148 | 7.5 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
1,844 | 63.58099 | 0 |
male
| 0 | 6 | 1,839 |
Colon Cancer
|
Cancer
| 1 | 12 | null | 0 | 5,187 | 3,958.7441 | null | 10 |
white
| 30.796875 | 30 | 0.543945 | 0.221985 | 1 | 0 | 0 |
metastatic
| 0.75 | 0.4 |
dnr after sadm
| 3 | 93 | 12.798828 | 98 | 24 | 36.59375 | null | 2.5 | 10.398438 | 1 | 133 | null | null | null | null | 4 | null |
no(M2 and SIP pres)
| 3.183199 |
1,845 | 92.29797 | 1 |
female
| 0 | 29 | 41 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | null | null | 9 | 19,765 | 14,352.9297 | null | 8.25 |
white
| 22.699219 | 38 | 0.678955 | 0.509888 | 1 | 0 | 0 |
no
| 0.8 | 0.55 |
dnr after sadm
| 1 | 97 | 15.298828 | 80 | 24 | 36.19531 | 233.3125 | 3.299805 | 1 | 2.399902 | 144 | 7.419922 | null | null | null | null | null |
<2 mo. follow-up
| 3.900879 |
1,846 | 74.409 | 1 |
male
| 0 | 12 | 69 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 26,899 | 17,381.4844 | null | 32.5 |
white
| 23.898438 | 25 | 0.759888 | 0.68396 | 2 | 0 | 0 |
no
| 0.8 | 0.6 |
dnr after sadm
| 2 | 47 | 12.099609 | 67 | 20 | 38.89844 | 320 | null | null | 1.099854 | 137 | 7.379883 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
1,847 | 88.172 | 1 |
male
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 0 | 6,992 | 2,529.5703 | null | 34 |
white
| 78.1875 | 73 | 0 | 0 | 1 | 1 | 0 |
no
| null | null |
dnr after sadm
| 2 | 0 | 10.699219 | 0 | 30 | 36.39844 | 312.5 | null | 1.299805 | 5.599609 | 126 | 7.389648 | null | null | null | null | null |
<2 mo. follow-up
| 1.862549 |
1,848 | 82.32697 | 1 |
male
| 1 | 6 | 6 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | null | null | 0 | 15,828 | 5,706.2148 | null | 46 |
white
| 39 | 58 | 0.287964 | 0.113998 | 1 | 1 | 1 |
no
| 0 | 0 |
dnr after sadm
| 5 | 42 | 17.398438 | 104 | 32 | 36.39844 | 218 | null | 1.599854 | 2.699707 | 145 | 7.329102 | null | null | null | null | 6 |
<2 mo. follow-up
| 6 |
1,849 | 95.41394 | 1 |
female
| 0 | 16 | 944 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 8 | null | 0 | 21,600 | 8,630.2812 | null | 23 |
white
| 27.5 | 58 | 0.599976 | 0.492981 | 1 | 0 | 0 |
no
| 0.3 | 0.3 |
no dnr
| 16 | 57 | 8.199219 | 77 | 40 | 38.89844 | 90 | null | 0.699951 | 1.599854 | 148 | 7.069336 | null | null | null | 4 | 4 |
adl>=4 (>=5 if sur)
| 4 |
1,850 | 76.12598 | 0 |
male
| 0 | 5 | 1,826 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$25-$50k
| 0 | 4,546 | 2,898.5039 | null | 11 |
white
| 15.398438 | 33 | 0.863892 | 0.773926 | 1 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 5 | 107 | 3.299805 | 80 | 21 | 37.19531 | 230 | null | null | 1.099854 | 131 | 7.379883 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,851 | 86.49097 | 1 |
male
| 0 | 114 | 294 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 19 |
under $11k
| 9 | 110,134 | 74,480.9375 | null | 9.25 |
white
| 24 | 34 | 0.690918 | 0.598999 | 1 | 0 | 1 |
no
| 0.75 | 0.75 |
no dnr
| 114 | 131 | 8.599609 | 78 | 28 | 36.69531 | 85 | 2.599609 | 0.599976 | 0.699951 | 140 | 7.529297 | null | null | null | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
1,852 | 70.21796 | 1 |
male
| 1 | 28 | 28 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
$11-$25k
| 0 | 27,165 | 17,051.6719 | null | 10 |
white
| 33 | 44 | 0.610962 | 0.505981 | 1 | 0 | 0 |
no
| 0.7 | 0.5 |
dnr after sadm
| 9 | 80 | 3 | 100 | 26 | 35 | 404.75 | 2.199707 | 1.899902 | 8.199219 | 135 | 7.539062 | null | null | null | 3 | 0 |
<2 mo. follow-up
| 0 |
1,853 | 69.84796 | 1 |
female
| 0 | 19 | 126 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
under $11k
| 9 | 27,437 | 11,603.9375 | null | 21.666656 |
hispanic
| 20.898438 | 19 | 0.764893 | 0.626953 | 1 | 0 | 0 |
yes
| 0.75 | 0.5 |
dnr after sadm
| 3 | 50 | 15 | 63 | 10 | 38 | 225 | 3.799805 | 0.199982 | 0.599976 | 137 | 7.379883 | null | null | null | null | 2 |
no(M2 and SIP pres)
| 2 |
1,854 | 48.909 | 1 |
male
| 0 | 111 | 410 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 6 |
under $11k
| 0 | 162,243 | 92,695.5 | null | 42 |
white
| 42.796875 | 53 | 0.587891 | 0.395996 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 111 | 47 | 18.296875 | 121 | 10 | 33.29688 | 249 | 2.599609 | 1.399902 | 1.199951 | 138 | 7.339844 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
1,855 | 70.65295 | 1 |
male
| 0 | 8 | 231 |
Colon Cancer
|
Cancer
| 3 | 5 |
$25-$50k
| 0 | 8,013 | 4,871.3359 | null | 2.5 |
white
| 15.5 | 25 | 0.826904 | 0.623901 | 1 | 0 | 0 |
metastatic
| 0.75 | 0.5 |
no dnr
| 8 | 77 | 8.699219 | 60 | 28 | 37.89844 | null | null | null | 1 | 143 | null | null | null | null | 0 | 2 |
no(M2 and SIP pres)
| 2 |
1,856 | 39.12698 | 0 |
female
| 0 | 18 | 1,823 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 9 | 19,532 | 14,328.2969 | null | 16.666656 |
white
| 22 | 31 | 0.882935 | 0.840942 | 1 | 0 | 0 |
no
| 0.99 | 0.95 |
no dnr
| 18 | 68 | 17.398438 | 144 | 28 | 38.39844 | 424 | null | null | 1.199951 | 136 | 7.439453 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
1,857 | 69.21295 | 1 |
female
| 1 | 9 | 9 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 19,470 | 5,971.9727 | null | 29.5 |
white
| 31.398438 | 71 | 0.652954 | 0.475952 | 1 | 0 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 9 | 53 | 21.898438 | 165 | 38 | 36.89844 | 203.6875 | 4.099609 | null | 2.399902 | 134 | 7.399414 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
1,858 | 19.75099 | 0 |
male
| 0 | 6 | 1,822 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
under $11k
| 0 | 8,945 | 3,473.5801 | null | 21 |
black
| 20 | 13 | 0.932983 | 0.907959 | 2 | 0 | 0 |
no
| 0.99 | 0.99 |
no dnr
| 6 | 113 | 14.599609 | 112 | 24 | 37.09375 | 245 | null | null | 0.899902 | 137 | 7.389648 | null | null | null | null | null |
no(M2 and SIP pres)
| 1.625244 |
1,859 | 65.87799 | 1 |
female
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
>$50k
| 0 | 10,435 | 3,580.7969 | null | 33 |
white
| 35.796875 | 59 | 0.565918 | 0.453979 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 4 | 47 | 15.099609 | 110 | 22 | 39.19531 | 150 | 2 | 2.5 | 1.599854 | 145 | 7.329102 | null | null | null | null | null |
<2 mo. follow-up
| 2.192383 |
1,860 | 85.89996 | 1 |
female
| 0 | 11 | 358 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 0 | 9,867 | 6,423.6914 | null | 12 |
white
| 16.796875 | 31 | 0.835938 | 0.780884 | 1 | 0 | 1 |
no
| 0.5 | 0.1 |
dnr after sadm
| 2 | 57 | 8.699219 | 64 | 20 | 37.39844 | null | 2.699707 | 1.799805 | 0.799927 | 142 | null | null | null | null | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
1,861 | 77.73895 | 1 |
male
| 1 | 121 | 121 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 20 |
$25-$50k
| 0 | 298,360 | 198,960.125 | null | 13.5 |
white
| 28.699219 | 44 | 0.668945 | 0.572998 | 1 | 0 | 0 |
no
| 0.99 | 0.9 |
dnr after sadm
| 120 | 132 | 10.398438 | 115 | 8 | 38.19531 | 141.65625 | 3.599609 | null | 2.599609 | 138 | 7.369141 | null | null | null | 0 | 0 |
adl>=4 (>=5 if sur)
| 0 |
1,862 | 88.03595 | 0 |
female
| 0 | 17 | 1,820 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 10 |
under $11k
| 0 | 15,815 | 12,376.2344 | null | 12.333328 |
white
| 19.097656 | 36 | 0.79895 | 0.73291 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 17 | 71 | 5.5 | 76 | 45 | 38.5 | 388 | null | 0.5 | 1.699951 | 137 | 7.40918 | null | null | null | 1 | 1 |
no(M2 and SIP pres)
| 1 |
1,863 | 71.66595 | 1 |
female
| 0 | 7 | 126 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 14 |
>$50k
| 0 | 7,804 | 6,189.3398 | null | 20 |
white
| 13.298828 | 20 | 0.898926 | 0.830933 | 1 | 0 | 0 |
no
| 0.9 | 0.7 |
no dnr
| 7 | 71 | 7.299805 | 74 | 20 | 36.29688 | 542.75 | 3.799805 | null | 1.299805 | 137 | 7.389648 | null | null | null | 0 | 0 | null | 0 |
1,864 | 70.31897 | 1 |
female
| 0 | 4 | 19 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 4,416 | 2,761.2207 | null | 17 |
white
| 15 | 12 | 0.733887 | 0.463989 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 4 | 60 | 5.199219 | 80 | 20 | 37.79688 | null | null | 1.099854 | 0.599976 | 135 | null | null | null | null | null | null |
<2 mo. follow-up
| 1.990967 |
1,865 | 69.14398 | 1 |
male
| 0 | 9 | 58 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
under $11k
| 0 | 10,137 | 5,123.7227 | null | 12.5 |
white
| 13.298828 | 16 | 0.906982 | 0.843994 | 1 | 0 | 0 |
no
| 0.95 | 0.65 |
no dnr
| 9 | 83 | 6.5 | 76 | 32 | 36.19531 | 337 | 4 | 0.5 | 0.799927 | 137 | 7.389648 | null | null | null | 3 | 1 |
no(M2 and SIP pres)
| 1 |
1,866 | 80.87097 | 1 |
female
| 0 | 9 | 1,174 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 0 | 10,512 | 4,263.2422 | null | 16.5 |
white
| 25.597656 | 49 | 0.672974 | 0.501953 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 9 | 77 | 17.296875 | 134 | 28 | 36.5 | 190.46875 | null | null | 0.899902 | 136 | 7.339844 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,867 | 72.67596 | 1 |
male
| 0 | 7 | 45 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 0 | 11,472 | 7,616.8633 | null | 19 |
white
| 22.898438 | 36 | 0.771973 | 0.698975 | 3 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 7 | 67 | 10.599609 | 62 | 26 | 36.09375 | 471.625 | 2.899902 | 1 | 1.799805 | 134 | 7.509766 | null | null | null | 0 | 1 |
<2 mo. follow-up
| 1 |
1,868 | 90.11597 | 1 |
female
| 0 | 12 | 27 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 5 |
under $11k
| 0 | 10,945 | 6,067.9414 | null | 9.5 |
white
| 15 | 28 | 0.793945 | 0.667969 | 1 | 0 | 0 |
no
| 0.9 | 0.7 |
dnr after sadm
| 1 | 93 | 5.399414 | 82 | 28 | 37 | 285.6875 | null | null | 1.099854 | 144 | 7.269531 | null | null | null | 5 | null |
<2 mo. follow-up
| 3.855299 |
1,869 | 91.88995 | 0 |
female
| 0 | 7 | 1,813 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null |
>$50k
| 0 | 5,870 | 3,882.2109 | null | 17 |
white
| 12.398438 | 35 | 0.863892 | 0.775879 | 1 | 0 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 1 | 75 | 8.699219 | 60 | 24 | 36.69531 | 400 | 4.599609 | null | 1.899902 | 135 | 7.259766 | null | null | null | null | 3 |
no(M2 and SIP pres)
| 3 |
1,870 | 85.29498 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 6 |
under $11k
| 26 | 22,704 | 10,671.1172 | null | 39 |
black
| 29.699219 | 41 | 0.376953 | 0.258972 | 10 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 3 | 63 | 19.199219 | 138 | 46 | 39.29688 | 173.3125 | 3.199707 | 1.199951 | 0.799927 | 132 | 7.429688 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
1,871 | 78.06195 | 1 |
male
| 0 | 16 | 36 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 6 | null | 0 | 12,894 | 8,858.2969 | null | 9.666664 |
white
| 21.699219 | 35 | 0.795898 | 0.670898 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 16 | 65 | 5.199219 | 98 | 32 | 36.19531 | null | 3.299805 | 0.5 | 1.599854 | 134 | null | null | null | null | 0 | 5 |
<2 mo. follow-up
| 5 |
1,872 | 77.36896 | 1 |
male
| 1 | 75 | 75 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 10 |
$11-$25k
| 9 | 159,774 | 82,870.6875 | null | 36.75 |
white
| 37.296875 | 45 | 0.284973 | 0.175995 | 15 | 0 | 0 |
no
| 0.95 | 0.8 |
dnr after sadm
| 68 | 43 | 5.699219 | 189 | 16 | 36.59375 | 153.03125 | 2.299805 | null | 0.799927 | 136 | 7.399414 | null | null | null | 4 | 3 |
no(M2 and SIP pres)
| 3 |
1,873 | 57.47598 | 1 |
female
| 0 | 17 | 59 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 | null | 0 | 27,525 | 15,043.7344 | null | 25.333328 |
hispanic
| 22.097656 | 30 | 0.61792 | 0.512939 | 7 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 17 | 111 | 6.199219 | 110 | 26 | 36.79688 | 250 | null | null | 1.299805 | 149 | 7.519531 | null | null | null | 0 | null |
adl>=4 (>=5 if sur)
| 0.4948 |
1,874 | 75.12097 | 0 |
female
| 0 | 121 | 1,809 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 | null | 0 | 171,895 | 117,669.438 | null | 27.75 |
white
| 31.597656 | 66 | 0.616943 | 0.511963 | 1 | 1 | 0 |
no
| 0.6 | 0.4 |
no dnr
| 121 | 53 | 15.599609 | 160 | 8 | 36.39844 | 248 | 3.399902 | 1.799805 | 2 | 146 | 7.209961 | null | null | null | null | 5 |
SIP>=30
| 5 |
1,875 | 36.16397 | 0 |
male
| 0 | 44 | 1,810 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 90,237 | 73,488.125 | null | 40.25 |
white
| 20.296875 | 22 | 0.901978 | 0.866943 | 3 | 0 | 0 |
no
| null | null |
no dnr
| 44 | 127 | 11 | 102 | 14 | 38.5 | 191.65625 | null | null | 0.899902 | 134 | 7.449219 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
1,876 | 76.10999 | 1 |
male
| 0 | 11 | 833 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 0 | null | 37 | 21,743 | 18,019.5156 | null | 35 |
white
| 25.199219 | 36 | 0.582886 | 0.472961 | 2 | 0 | 1 |
no
| 0.75 | 0.25 |
no dnr
| 11 | 113 | 12.798828 | 70 | 28 | 38.79688 | 103 | null | null | 1.399902 | 143 | 7.489258 | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 5.44043 |
1,877 | 87.13995 | 1 |
female
| 1 | 12 | 12 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 19,842 | 5,105.0781 | null | 34 |
white
| 32 | 46 | 0.449951 | 0.329956 | 1 | 0 | 0 |
yes
| 0.1 | 0.001 |
dnr after sadm
| 4 | 43 | 7.099609 | 114 | 12 | 38.19531 | 285 | 4 | 1.199951 | 2.099609 | 143 | 7.439453 | null | null | null | null | null |
<2 mo. follow-up
| 3.121582 |
1,878 | 76.80194 | 1 |
female
| 0 | 13 | 713 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 32,927 | 20,705.5312 | null | 27 |
white
| 22 | 33 | 0.72998 | 0.576904 | 5 | 1 | 0 |
no
| 0.8 | 0.65 |
no dnr
| 13 | 72 | 16.097656 | 102 | 28 | 38.09375 | 177.53125 | null | null | 1.399902 | 138 | 7.509766 | null | null | null | null | 1 |
no(M2 and SIP pres)
| 1 |
1,879 | 85.62097 | 1 |
female
| 0 | 17 | 1,057 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 12 |
$25-$50k
| 0 | 13,883 | 8,324.8047 | null | 7.666664 |
white
| 26.898438 | 46 | 0.662964 | 0.487976 | 1 | 0 | 0 |
no
| 0.98 | 1 |
no dnr
| 17 | 53 | 5.699219 | 69 | 30 | 38 | 126.51562 | null | 0.599976 | 1.699951 | 136 | 7.369141 | null | null | null | 1 | 0 |
SIP>=30
| 0 |
1,880 | 82.83099 | 1 |
female
| 0 | 5 | 139 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$25-$50k
| 0 | 7,412 | 3,651.3867 | null | 15 |
white
| 19.796875 | 45 | 0.766968 | 0.628906 | 1 | 0 | 0 |
no
| 0.9 | 0.6 |
dnr after sadm
| 2 | 65 | null | 71 | 35 | 36.89844 | 220 | 3.799805 | 0.5 | 3 | 140 | 7.379883 | null | null | null | 6 | null |
adl>=4 (>=5 if sur)
| 4.527397 |
1,881 | 67.26099 | 1 |
female
| 0 | 8 | 49 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 14 |
$11-$25k
| 0 | 9,286 | 5,743.0938 | null | 8.5 |
black
| 15.599609 | 20 | 0.895996 | 0.824951 | 1 | 0 | 0 |
no
| 0.9 | 0.85 |
no dnr
| 8 | 113 | 6.899414 | 90 | 24 | 37.79688 | 421.625 | 3.299805 | 0.299988 | 1.5 | 144 | 7.379883 | null | null | null | 1 | 1 |
<2 mo. follow-up
| 1 |
1,882 | 78.07794 | 1 |
female
| 0 | 19 | 355 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 15 |
$25-$50k
| 0 | 13,959 | 9,974.7891 | null | 8 |
white
| 15.898438 | 32 | 0.848999 | 0.751953 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
dnr after sadm
| 1 | 67 | 4.699219 | 80 | 20 | 36.69531 | 220 | null | null | 0.799927 | 133 | 7.5 | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
1,883 | 48.05698 | 1 |
female
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 19 |
>$50k
| 0 | 9,250 | 2,868.1894 | null | 30 |
white
| 49.5 | 56 | 0.036995 | 0.009998 | 1 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 3 | 49 | 1.5 | 124 | 44 | 34.59375 | 145 | 2.799805 | 0.599976 | 0.699951 | 130 | 7.439453 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
1,884 | 70.75195 | 1 |
female
| 0 | 20 | 179 |
Lung Cancer
|
Cancer
| 2 | null | null | 0 | 19,308 | 13,598.2031 | null | 7.666664 |
white
| 15.898438 | 15 | 0.716919 | 0.438965 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.7 |
no dnr
| 20 | 103 | 12.898438 | 76 | 16 | 36.69531 | null | 3.399902 | 0.5 | 0.899902 | 141 | null | null | null | null | null | null | null | 2.953125 |
1,885 | 85.06494 | 1 |
female
| 0 | 13 | 82 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 0 | 15,635 | 7,769.6562 | null | 18 |
white
| 22.597656 | 35 | 0.754883 | 0.67688 | 1 | 1 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 13 | 50 | 11.898438 | 85 | 20 | 37.89844 | 235 | 3.599609 | 0.5 | 0.799927 | 133 | 7.319336 | null | null | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
1,886 | 43.21399 | 1 |
female
| 0 | 10 | 322 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 21 |
>$50k
| 0 | 22,535 | 9,573.2734 | null | 22.5 |
white
| 30.296875 | 62 | 0.720947 | 0.564941 | 1 | 0 | 0 |
no
| 0.6 | 0.33 |
no dnr
| 10 | 58 | 11.298828 | 132 | 56 | 38.89844 | 261.875 | 2.399902 | 2.599609 | 0.399963 | 145 | 7.509766 | null | null | null | null | 3 | null | 3 |
1,887 | 61.862 | 1 |
female
| 0 | 96 | 1,362 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
under $11k
| 0 | 139,856 | 89,639.3125 | null | 35 |
black
| 30 | 62 | 0.730957 | 0.578979 | 1 | 1 | 0 |
no
| 0.7 | 0.65 |
dnr after sadm
| 6 | 53 | 11.898438 | 69 | 32 | 38.69531 | 316 | 2.799805 | null | 6.699219 | 137 | 7.229492 | null | null | null | null | 2 |
SIP>=30
| 2 |
1,888 | 55.64099 | 1 |
male
| 0 | 11 | 49 |
Lung Cancer
|
Cancer
| 1 | 14 | null | 0 | 12,424 | 7,868.0664 | null | 22 |
white
| 13.898438 | 17 | 0.781982 | 0.543945 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.25 |
no dnr
| 11 | 103 | 7 | 88 | 16 | 37.79688 | null | null | 0.399963 | 1.199951 | 133 | null | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
1,889 | 57.35199 | 1 |
male
| 0 | 5 | 118 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 9 | 5,977 | 3,633.5742 | null | 11 |
white
| 19.296875 | 53 | 0.643921 | 0.335999 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.2 |
no dnr
| 5 | 70 | 0.799927 | 100 | 26 | 38.79688 | 328.5625 | null | null | 1.5 | 133 | 7.479492 | null | null | null | null | null |
no(M2 and SIP pres)
| 2.203613 |
1,890 | 55.66098 | 1 |
female
| 0 | 12 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 30,821 | 22,212.0469 | null | 33 |
white
| 33.09375 | 31 | 0.640991 | 0.539917 | 4 | 0 | 0 |
no
| 0.5 | 0.2 |
no dnr
| 12 | 53 | 13.599609 | 109 | 32 | 39.09375 | 118.32812 | null | null | 0.799927 | 134 | 7.419922 | null | null | null | 0 | 0 |
<2 mo. follow-up
| 0 |
1,891 | 27.228 | 0 |
male
| 0 | 100 | 1,790 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 95,692 | 65,816.625 | null | 14.75 |
white
| 20.699219 | 16 | 0.917969 | 0.888916 | 2 | 0 | 0 |
no
| 0.95 | 0.8 |
no dnr
| 100 | 106 | 13.898438 | 135 | 22 | 37.89844 | 236.65625 | null | null | 1.099854 | 145 | 7.439453 | null | null | null | null | null | null | 2.666504 |
1,892 | 64.76898 | 0 |
female
| 0 | 44 | 1,790 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 44 | 67,778 | 34,829.25 | null | 26.75 |
white
| 23.199219 | 60 | 0.68689 | 0.593994 | 1 | 1 | 0 |
no
| 0.3 | 0.25 |
no dnr
| 44 | 59 | 16.199219 | 67 | 32 | 38.09375 | 185.6875 | 2.799805 | 0.399963 | 8.898438 | 144 | 7.459961 | null | null | null | null | 0 |
SIP>=30
| 0 |
1,893 | 89.05695 | 1 |
female
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 20 |
under $11k
| 89 | 21,707 | 9,177.0938 | null | 20 |
white
| 20.699219 | 41 | 0.330994 | 0.215973 | 4 | 0 | 0 |
no
| 0.05 | 0.000125 |
dnr after sadm
| 2 | 59 | 8.5 | 115 | 36 | 38.39844 | 235 | 3.799805 | null | 1.199951 | 150 | 7.419922 | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
1,894 | 75.625 | 1 |
male
| 0 | 35 | 300 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 12 |
under $11k
| 0 | 33,324 | 21,974.6406 | null | 7.75 |
black
| 15.798828 | 21 | 0.861938 | 0.771973 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
dnr after sadm
| 16 | 72 | 8.599609 | 73 | 16 | 36 | 237.125 | 3.199707 | 0.399963 | 1 | 135 | 7.399414 | null | null | null | 7 | null | null | 5.199497 |
1,895 | 51.56998 | 1 |
female
| 0 | 8 | 1,286 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 14 |
$25-$50k
| 0 | 7,933 | 5,171.043 | null | 10 |
white
| 20.5 | 18 | 0.908936 | 0.846924 | 1 | 0 | 0 |
no
| 0.98 | 0.98 |
no dnr
| 8 | 73 | 12.699219 | 110 | 25 | 38.29688 | 329.625 | null | 0.699951 | 0.699951 | 146 | 7.399414 | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
1,896 | 76.18896 | 1 |
female
| 0 | 46 | 283 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 0 | 58,865 | 32,778.4062 | null | 19.5 |
white
| 19 | 21 | 0.837891 | 0.782959 | 1 | 0 | 0 |
no
| 0.3 | 0.1 |
dnr after sadm
| 5 | 57 | 10.199219 | 63 | 6 | 38.19531 | 294.25 | 3.799805 | 0.399963 | 0.699951 | 132 | 7.439453 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
1,897 | 64.66498 | 0 |
female
| 0 | 4 | 1,783 |
Lung Cancer
|
Cancer
| 3 | 15 |
under $11k
| 0 | 3,253 | 2,141.6816 | null | 11 |
white
| 15.798828 | 22 | 0.731934 | 0.460999 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 4 | 117 | 6.5 | 72 | 28 | 36.39844 | null | null | null | 1.099854 | 137 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,898 | 89.62598 | 0 |
female
| 0 | 6 | 1,781 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 16 |
>$50k
| 0 | 6,769 | 4,204.9414 | null | 9 |
white
| 21.898438 | 51 | 0.671997 | 0.5 | 1 | 0 | 0 |
no
| 1 | 0.8 |
no dnr
| 6 | 93 | 15.398438 | 80 | 40 | 36.09375 | 220 | 3.399902 | 0.5 | 1.699951 | 139 | 7.469727 | null | null | null | 2 | 5 |
SIP>=30
| 5 |
1,899 | 71.77295 | 1 |
male
| 0 | 7 | 28 |
Colon Cancer
|
Cancer
| 2 | 12 |
$25-$50k
| 0 | 6,365 | 4,270.9492 | null | 13 |
white
| 25.597656 | 29 | 0.644897 | 0.336975 | 1 | 1 | 0 |
metastatic
| 0.05 | 0.000125 |
dnr after sadm
| 3 | 103 | 2.399902 | 76 | 20 | 37.79688 | null | 2.199707 | 0.5 | 0.899902 | 142 | null | null | null | null | 3 | 5 |
<2 mo. follow-up
| 5 |
1,900 | 77.72998 | 0 |
female
| 0 | 3 | 1,780 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 16 | null | 0 | 2,752 | 1,723.9951 | null | 16 |
white
| 16.597656 | 20 | 0.842896 | 0.74292 | 1 | 0 | 0 |
no
| 0.95 | 0.85 |
no dnr
| 3 | 120 | 7.599609 | 60 | 24 | 36.19531 | 380 | null | null | 1.099854 | 144 | 7.469727 | null | null | null | null | null | null | 2.211426 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.